TXN and cancer: In the present study, high Trx expression was identified as a good prognostic marker in patients with PDAC; this finding was in contrast to that of several in vitro studies, which suggest the utility of therapeutically targeting the Trx/TrxR system in cancer cells alone or in combination with chemotherapy or radiotherapy [12,23,49,50,51,52].